Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs Standard NMB and Low vs Standard Insufflation in Laparoscopic Cholecystectomy
NCT01728584Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2012
- Primary completion
- Apr 2014
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of Sugammadex in gallbladder disease, sponsored by Merck & Co.. Started Nov 2012; status: completed.
02
Drugs
Sugammadex
03
Conditions
gallbladder disease
Beyond the preview
Go deeper on NCT01728584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01728584.